On November 6, 2015, Inside EPA included comments made by Richard E. Engler, Ph. D. at a public meeting held by EPA, USDA, and FDA to  update the federal coordinated framework for how the three agencies regulate biotechnology. […]Industry officials, meanwhile, emphasized biotechnology's growing importance in food production and cautioned that over-regulation will stifle innovation. Officials with Dupont and the law firm Bergeson & Campbell, P.C., which represents industry clients, called for science-based assessments that consider products' risks and ... read more >

The November 2, 2015, BNA Daily Environment Report article, “New Authority Not Expected for Biotech Framework Update,” included comments made by Richard E. Engler, Ph.D. at the “Modernizing the Regulatory System for Biotechnology Products” public meeting held by FDA, USDA, and EPA.     […DuPont global director of corporate regulatory affairs Terry] Medley and Richard Engler, a senior chemist working for Bergeson & Campbell P.C., said the update needs to provide public confidence in the regulatory oversight process, so that the public can ... read more >

The October 26, 2015, Inside EPA article, “TSCA Reform Legislation Could Smooth Path For New Biotechnologies,” included comments made by Lynn L. Bergeson at an event hosted by the Wilson Center’s Synthetic Biology Project (synbio). Pending legislation in Congress to reform the 40-year-old Toxic Substances Control Act (TSCA) could make it easier for EPA to assess the potential risks of new technologies, such as synthetic biology, and review requests to undertake field research or commercialize new products, an industry attorney says. While the legislation does not ... read more >

On October 15, 2015, Bergeson & Campbell, P.C. (B&C®) and the Woodrow Wilson International Center for Scholars (Wilson Center) hosted “Leveraging Synthetic Biology’s Promise and Managing Potential Risk,” a panel discussion featuring Lynn L. Bergeson, Sheryl Lindros Dolan, and Richard E. Engler, Ph.D., of B&C, and Todd Kuiken, Ph.D., Senior Program Associate, Synthetic Biology Project, Wilson Center. The event coincided with the release of “The DNA of the U.S. Regulatory System: Are We Getting It Right For Synthetic Biology?,” authored by the ... read more >

Panel Discussion to Be Held Wednesday, October 15, 2015, from 12:00 p.m. - 2:00 p.m. (EDT) On October 15, 2015, the Woodrow Wilson International Center for Scholars (Wilson Center) will host "Leveraging Synthetic Biology's Promise and Managing Potential Risk," a panel discussion featuring Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), and Todd Kuiken, Ph.D., Senior Program Associate, Synthetic Biology Project, Wilson Center. The event coincides with the release of "The DNA of the U.S. Regulatory System: Are We Getting It Right For ... read more >

A September 3, 2015, Inside EPA article regarding EPA’s efforts to improve how it reviews companies’ proposals to develop synthetic biology products, and specifically biotech algae, featured quotes from Bergeson & Campbell, P.C.: In a recent memo to clients, the law firm Bergeson & Campbell calls the announcement of the algae guide update "hugely important for the industrial biotechnology communities," adding that "EPA's announcement suggests a broader Agency initiative is underway, and is best read in the context of other relevant ... read more >

The July 31, 2015, Bloomberg BNA Daily Environment Report spoke with Lynn L. Bergeson regarding EPA’s plans to develop updated guidance for companies making chemicals with genetically engineered microorganisms under the Toxic Substances Control Act (TSCA). “EPA's posting of the synbio algae project is hugely important for the industrial biotechnology and synthetic biology communities,” Lynn  Bergeson, managing partner of Bergeson  & Campbell P.C., told Bloomberg BNA in an e-mail. Her law firm specializes in policies for emerging technologies ... read more >

The April 7, 2015, Bloomberg BNA Daily Environment Report story "Innovation Outpacing Regulatory Systems; Modernized TSCA, New Data Said to Help," reported on "21st Century Understanding of Chemicals," a congressional briefing hosted by the American Chemical Society (ACS) Science & the Congress Project.  Lynn L. Bergeson’s comments at the congressional briefing were quoted.   The Environmental Protection Agency has taken eight times longer to approve new nanoengineered chemicals than new chemicals made with traditional technologies and feedstocks, an attorney specializing in ... read more >

Article Featured in Industrial Biotechnology Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®) and Of Counsel with the Biobased and Renewable Products Advocacy Group (BRAG®), Charles M. Auer of Charles Auer & Associates, LLC, and Oscar Hernandez, Ph.D. of Oscar Hernandez & Associates, LLC, have published "Creative Adaptation: Enhancing Oversight of Synthetic Biology Under the Toxic Substances Control Act" in the October 2014 issue of Industrial Biotechnology, the journal of biobased innovation to drive the global bioeconomy. In the ... read more >